Assessment of Pharmacokinetic, Pharmacodynamic Profile, and Tolerance of Gadopiclenol, A New High Relaxivity GBCA, in Healthy Subjects and Patients With Brain Lesions (Phase I/IIa Study)
2019
ObjectivesThe aim of this study was to evaluate the pharmacokinetics, safety profile, and pharmacodynamics of gadopiclenol, a new high relaxivity macrocyclic gadolinium-based contrast agent, in healthy subjects and patients with brain lesions.Materials and MethodsThis was a single ascending dose pha
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
29
References
10
Citations
NaN
KQI